Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
03/09/1995 | CA2170508A1 Benzazole compounds for use in therapy |
03/09/1995 | CA2170393A1 Cloning of a member of the serine-threonine-kinase family |
03/09/1995 | CA2170390A1 Immunoreactive peptide sequence from a 43 kd human cancer antigen |
03/09/1995 | CA2169557A1 Treatment of human tumors by genetic transformation of human tumor cells |
03/08/1995 | EP0641791A1 Novel benzothiophene derivative |
03/08/1995 | EP0641785A1 Triazolylated tertiary amine compound or salt thereof |
03/08/1995 | EP0641779A1 Novel 1-amidinopiperdines and 4-amidinomorpholines as aggregation inhibitions |
03/08/1995 | EP0641767A1 Cytotoxic stilbene derivatives and pharmaceutical composition containing them |
03/08/1995 | EP0641565A1 Contraceptive and menstrual cycle controlling drug having oncostatic properties |
03/08/1995 | EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens |
03/08/1995 | EP0641359A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
03/08/1995 | EP0641358A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR |
03/08/1995 | EP0641355A1 Steroid sulphatase inhibitors |
03/08/1995 | EP0641342A1 Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines |
03/08/1995 | EP0641334A1 Novel taxane derivatives, their preparation and compositions containing same |
03/08/1995 | EP0641327A1 Novel alpha-mannosidase inhibitors |
03/08/1995 | EP0641211A1 INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY |
03/08/1995 | EP0641207A1 Enantiomeric cynemicin analogs, preparation and use thereof |
03/08/1995 | EP0641193A1 Chemotherapeutic drug combinations |
03/08/1995 | CN1099802A Tumor necrosis factor muteins |
03/08/1995 | CN1099760A Cyclic adhesion inhibitors |
03/08/1995 | CN1099759A 哌嗪衍生物 Piperazine derivatives |
03/08/1995 | CN1099756A Tetrahydropyran derivatives |
03/08/1995 | CN1099755A Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
03/08/1995 | CN1099753A Derivatives of amino-ascorbic acid, processes for their preparation and use |
03/08/1995 | CN1099612A Destroying or inhibiting growth of unwanted cells or tissues |
03/08/1995 | CA2130864A1 Carboxamides |
03/07/1995 | US5395850 Antitumor agents |
03/07/1995 | US5395842 Inhibitors of sex steroids |
03/07/1995 | CA1334671C Mitomycin phosphate derivatives |
03/07/1995 | CA1334668C 13-alkyl-11beta-phenylgonanes |
03/02/1995 | WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy |
03/02/1995 | WO1995006067A1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
03/02/1995 | WO1995006065A1 Cytokines that bind the cell surface receptor hek |
03/02/1995 | WO1995006054A1 Compound uch9 |
03/02/1995 | WO1995006040A1 Benzodiazepine compounds useful as antagonists of cck or of gastrine |
03/02/1995 | WO1995006020A1 New diphenylhexene |
03/02/1995 | WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
03/02/1995 | WO1995005847A1 Accessory factor function for interferon gamma and its receptor |
03/02/1995 | WO1995005839A1 Nigella sativa as a medicinal treatment |
03/02/1995 | WO1995005835A1 Gene therapy for solid tumors, papillomas and warts |
03/02/1995 | WO1995005829A1 Therapeutic system for treating psoriasis |
03/02/1995 | WO1995005821A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones |
03/02/1995 | WO1995005818A1 Photosensitizers |
03/02/1995 | WO1995005750A1 Cell death regulator |
03/02/1995 | WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
03/02/1995 | DE4425481A1 Melanoma-inhibiting protein |
03/02/1995 | CA2170159A1 Recombinant cells from the monocyte-macrophage cell ligne for gene therapy |
03/02/1995 | CA2169956A1 Nigella sativa as a medicinal treatment |
03/02/1995 | CA2169851A1 Cytokines that bind the cell surface receptor hek |
03/02/1995 | CA2169849A1 Accessory factor function for interferon gamma and its receptor |
03/02/1995 | CA2169750A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones |
03/02/1995 | CA2169089A1 Benzodiazepine derivatives |
03/02/1995 | CA2168882A1 Therapeutic system for treating psoriasis |
03/02/1995 | CA2147612A1 Compound uch9 |
03/01/1995 | EP0640614A2 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates |
03/01/1995 | EP0640613A1 OLIGOSIALYL-1,2-DIALKYL-Sn-GLYCEROL AND INTERMEDIATE FOR ITS SYNTHESIS |
03/01/1995 | EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them |
03/01/1995 | EP0640346A1 Uses of sulphated sugars against inflammation |
03/01/1995 | EP0640131A1 Genetically engineered antibodies |
03/01/1995 | EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use |
03/01/1995 | EP0639982A1 Use of mmp inhibitors |
03/01/1995 | EP0639981A1 Igf-1 analogs |
03/01/1995 | EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
03/01/1995 | EP0639977A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
03/01/1995 | EP0580753B1 Pyrimidine derivatives for enhancing antitumor activity |
03/01/1995 | EP0406428B1 Peptide derivatives and their use |
03/01/1995 | CN1099295A Application plaster for treatment of carcinosis pain |
03/01/1995 | CN1099264A Cell differentiation inducer comprising acyclic polyisoprenoid |
02/28/1995 | US5393897 Isolation and structure of spongistatins 5,7,8 and 9 |
02/28/1995 | US5393896 Treating ground yew parts with water, separating aqueous solution, extracting with organic solvent, desolventizing, crystallizing, isolating |
02/28/1995 | US5393889 Water soluble bis-dioxopiperazine derivatives |
02/28/1995 | US5393760 Guanidine derivatives |
02/28/1995 | US5393741 Anticarcinogenic agents |
02/28/1995 | US5393737 Cytotoxic drug conjugates for treatment of neoplastic diseases |
02/26/1995 | CA2130385A1 Inhibition of phosphatidylinositol 3-kinase with 17.beta.-hydroxywortmannin and analogs thereof |
02/24/1995 | CA2130230A1 Sugar-modified interferon |
02/23/1995 | WO1995005375A1 Indole derivatives as 5-alpha-reductase-1-inhibitors |
02/23/1995 | WO1995005365A1 New bis-naphthalimides for the treatment of cancer |
02/23/1995 | WO1995005359A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
02/23/1995 | DE4407538C1 Binding reagent for cell surface protein and effector cell |
02/23/1995 | DE3991484C2 Pharmaceutical composition containing a specific inhibitor of the enzymatic conversion of protoporphyrinogen to protoporphyrin IX by protoporphyrinogen oxidase |
02/23/1995 | CA2169059A1 New bis-naphthalimides for the treatment of cancer |
02/23/1995 | CA2167156A1 Bicyclo(2.2.2) octane derivatives cholecystokinin and/or gastin antagonists |
02/22/1995 | EP0639577A1 Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents |
02/22/1995 | EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production |
02/22/1995 | EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it |
02/22/1995 | EP0639380A1 Cyclodextrin inclusion product of taxol, process for producing the same, and its use |
02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
02/22/1995 | EP0639186A1 Taxol derivatives |
02/22/1995 | EP0639183A1 Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents |
02/22/1995 | EP0639182A1 Quinoline derivatives |
02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
02/22/1995 | EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents |
02/22/1995 | EP0526502B1 Phenolic amine depigmenting and antimelanoma agents |
02/22/1995 | CN1099040A Linear adhesion inhibitor |
02/22/1995 | CN1099032A Derivative of benzoxazine, preparation and pharmaceutical application of same |
02/22/1995 | CN1098937A 998 Chinese medicinal pellet for treatment of primary carcinoma of liver |
02/22/1995 | CN1098934A Anti-cancer compn. and prepn. thereof |
02/21/1995 | US5391800 Protecting hydroxyl groups of sphingosine, deprotecting C1, phosphorylating, deprotecting C3; free of L-threo isomer |